Despite significant progress in cancer treatments, the benefits are not experienced equally across different socioeconomic groups.
CureVac Announces Financial Results for the Second Quarter and First Half of 2024 and Provides Business Update – Biotech Investments
Issuer: CureVac / Key word(s): Quarter Results 15.08.2024 / 13:06 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac Announces Financial